2009
DOI: 10.1523/jneurosci.1526-09.2009
|View full text |Cite
|
Sign up to set email alerts
|

PACAP Neurons in the Hypothalamic Ventromedial Nucleus Are Targets of Central Leptin Signaling

Abstract: The adipose-derived hormone, leptin, was discovered over 10 years ago, but only now are we unmasking its downstream pathways which lead to reduced energy intake (feeding) and increased energy expenditure (thermogenesis). Recent transgenic models have challenged the longstandingsuppositionthatthehypothalamicarcuatenucleus (

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

11
140
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 93 publications
(152 citation statements)
references
References 62 publications
11
140
1
Order By: Relevance
“…Importantly, site-specific hypothalamic injections do not cause sedation or aversive effects (50) that can sometimes arise following exogenous peptide administration. Although there are multiple PACAP receptor subtypes expressed in the hypothalamus, the reduction in feeding behavior appears to be mediated primarily by the PAC1R subtype, which is in agreement with prior feeding studies (27,40,50). Specifically, in both the PVN and VMN, the effects of PACAP could be blocked by the VPAC2R/PAC1R antagonist PACAP(6 -38) but not by the VPAC1R/VPAC2R antagonist VIP (6 -28).…”
Section: Discussionsupporting
confidence: 83%
See 4 more Smart Citations
“…Importantly, site-specific hypothalamic injections do not cause sedation or aversive effects (50) that can sometimes arise following exogenous peptide administration. Although there are multiple PACAP receptor subtypes expressed in the hypothalamus, the reduction in feeding behavior appears to be mediated primarily by the PAC1R subtype, which is in agreement with prior feeding studies (27,40,50). Specifically, in both the PVN and VMN, the effects of PACAP could be blocked by the VPAC2R/PAC1R antagonist PACAP(6 -38) but not by the VPAC1R/VPAC2R antagonist VIP (6 -28).…”
Section: Discussionsupporting
confidence: 83%
“…Expression of multiple PACAP receptor subtypes in the hypothalamus suggests that PACAP is a multifunctional neuropeptide signal that contributes to several behavioral and physiological systems. The feasibility of this concept is supported by reports linking PACAP to stress (51), anxiety (22), feeding (27,40,50), and glucose mobilization (60), all systems that may work synergistically and converge on PACAP-enriched anatomic areas such as the hypothalamus and amygdala (25).…”
Section: Discussionmentioning
confidence: 96%
See 3 more Smart Citations